Advertisement
Screener

Corvus Pharmaceuticals, Inc. (CRVS) Increase (Decrease) in Prepaid Expense and Other Assets

Corvus Pharmaceuticals, Inc. Increase (Decrease) in Prepaid Expense and Other Assets

Corvus Pharmaceuticals, Inc. (CRVS) reported Increase (Decrease) in Prepaid Expense and Other Assets of $4.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-06

  • Corvus Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $2.54M, a 2821.84% increase year-over-year.
  • Corvus Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $1.76M.
  • Corvus Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $204.00K, a 82.53% decline year-over-year.
  • Corvus Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$64.00K, a 128.70% decline year-over-year.
  • Corvus Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$941.00K, a 159.29% decline from fiscal 2024.
  • Corvus Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $1.59M, a 19737.50% increase from fiscal 2023.
  • Corvus Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $8.00K.
  • Corvus Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$581.00K, a 309.75% decline from fiscal 2021.
Period endIncrease (Decrease) in Prepaid Expense and Other Assets 3 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 monthIncrease (Decrease) in Prepaid Expense and Other Assets 6 month as first filedIncrease (Decrease) in Prepaid Expense and Other Assets 9 monthIncrease (Decrease) in Prepaid Expense and Other Assets 11 monthIncrease (Decrease) in Prepaid Expense and Other Assets 12 month
2026-06-30$2.54M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$4.30M
10-Q · filed 2026-08-06
$4.51M
derived: sum of 3 quarters · filed 2026-08-06
$4.44M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$1.76M
10-Q · filed 2026-05-07
$1.97M
derived: sum of 2 quarters · filed 2026-05-07
$1.90M
derived: sum of 3 quarters · filed 2026-05-07
$1.99M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$204.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
$140.00K
derived: sum of 2 quarters · filed 2026-03-12
$227.00K
derived: sum of 3 quarters · filed 2026-08-06
-$941.00K
10-K · filed 2026-03-12
2025-09-30-$64.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$23.00K
derived: sum of 2 quarters · filed 2026-08-06
-$1.15M
10-Q · filed 2025-11-04
$23.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$87.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$1.08M
10-Q · filed 2026-08-06
$87.00K
derived: sum of 3 quarters · filed 2026-08-06
$310.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$1.17M
10-Q · filed 2026-05-07
$0.00
derived: sum of 2 quarters · filed 2026-05-07
$223.00K
derived: sum of 3 quarters · filed 2026-05-07
$503.00K
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$1.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
$1.39M
derived: sum of 2 quarters · filed 2026-03-12
$1.67M
derived: sum of 3 quarters · filed 2026-03-12
$1.59M
10-K · filed 2026-03-12
2024-09-30$223.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$503.00K
derived: sum of 2 quarters · filed 2025-11-04
$419.00K
10-Q · filed 2025-11-04
$285.00K
derived: sum of 4 quarters · filed 2026-03-12
2024-06-30$280.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$196.00K
10-Q · filed 2025-08-07
$62.00K
derived: sum of 3 quarters · filed 2026-03-12
$84.00K
derived: sum of 4 quarters · filed 2026-03-12
2024-03-31-$84.00K
10-Q · filed 2025-05-08
-$218.00K
derived: sum of 2 quarters · filed 2026-03-12
-$196.00K
derived: sum of 3 quarters · filed 2026-03-12
$42.00K
derived: sum of 4 quarters · filed 2026-03-12
2023-12-31-$134.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12
-$112.00K
derived: sum of 2 quarters · filed 2026-03-12
$126.00K
derived: sum of 3 quarters · filed 2026-03-12
$8.00K
10-K · filed 2026-03-12
2023-09-30$22.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
$260.00K
derived: sum of 2 quarters · filed 2024-11-12
$142.00K
10-Q · filed 2024-11-12
-$237.00K
derived: sum of 4 quarters · filed 2025-03-25
2023-06-30$238.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
$120.00K
10-Q · filed 2024-08-06
-$259.00K
derived: sum of 3 quarters · filed 2025-03-25
-$896.00K
derived: sum of 4 quarters · filed 2025-03-25
2023-03-31-$118.00K
10-Q · filed 2024-05-07
-$497.00K
derived: sum of 2 quarters · filed 2025-03-25
-$1.13M
derived: sum of 3 quarters · filed 2025-03-25
-$395.00K
derived: sum of 4 quarters · filed 2025-03-25
2022-12-31-$379.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25
-$1.02M
derived: sum of 2 quarters · filed 2025-03-25
-$277.00K
derived: sum of 3 quarters · filed 2025-03-25
-$581.00K
10-K · filed 2025-03-25
2022-09-30-$637.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
$102.00K
derived: sum of 2 quarters · filed 2023-11-07
-$202.00K
10-Q · filed 2023-11-07
-$1.00M
derived: sum of 4 quarters · filed 2024-03-19
2022-06-30$739.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
$435.00K
10-Q · filed 2023-08-08
-$363.00K
derived: sum of 3 quarters · filed 2024-03-19
-$868.00K
derived: sum of 4 quarters · filed 2024-03-19
2022-03-31-$304.00K
10-Q · filed 2023-05-08
-$1.10M
derived: sum of 2 quarters · filed 2024-03-19
-$1.61M
derived: sum of 3 quarters · filed 2024-03-19
$210.00K
derived: sum of 4 quarters · filed 2024-03-19
2021-12-31-$798.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19
-$1.30M
derived: sum of 2 quarters · filed 2024-03-19
$514.00K
derived: sum of 3 quarters · filed 2024-03-19
$277.00K
10-K · filed 2024-03-19
2021-09-30-$505.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$1.31M
derived: sum of 2 quarters · filed 2022-11-03
$1.07M
10-Q · filed 2022-11-03
$1.00M
derived: sum of 4 quarters · filed 2023-03-28
2021-06-30$1.82M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08
$1.58M
10-Q · filed 2022-08-08
$1.58M
10-Q · filed 2021-08-02
$1.51M
derived: sum of 3 quarters · filed 2023-03-28
$1.35M
derived: sum of 4 quarters · filed 2023-03-28
2021-03-31-$237.00K
10-Q · filed 2022-05-05
-$308.00K
derived: sum of 2 quarters · filed 2023-03-28
-$463.00K
derived: sum of 3 quarters · filed 2023-03-28
-$296.00K
derived: sum of 4 quarters · filed 2023-03-28
2020-12-31-$71.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28
-$226.00K
derived: sum of 2 quarters · filed 2023-03-28
-$59.00K
derived: sum of 3 quarters · filed 2023-03-28
-$285.00K
10-K · filed 2023-03-28
2020-09-30-$155.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01
$12.00K
derived: sum of 2 quarters · filed 2021-11-01
-$214.00K
10-Q · filed 2021-11-01
-$263.00K
derived: sum of 4 quarters · filed 2022-03-10
2020-06-30$167.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-02
-$59.00K
10-Q · filed 2021-08-02
-$108.00K
derived: sum of 3 quarters · filed 2022-03-10
-$2.00K
derived: sum of 4 quarters · filed 2022-03-10
2020-03-31-$226.00K
10-Q · filed 2021-04-29
-$275.00K
derived: sum of 2 quarters · filed 2022-03-10
-$169.00K
derived: sum of 3 quarters · filed 2022-03-10
-$61.00K
derived: sum of 4 quarters · filed 2022-03-10
2019-12-31-$49.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10
$57.00K
derived: sum of 2 quarters · filed 2022-03-10
$165.00K
derived: sum of 3 quarters · filed 2022-03-10
$370.00K
10-K · filed 2022-03-10
2019-09-30$106.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29
$214.00K
derived: sum of 2 quarters · filed 2020-10-29
$419.00K
10-Q · filed 2020-10-29
-$476.00K
derived: sum of 4 quarters · filed 2021-03-25
2019-06-30$108.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30
$313.00K
10-Q · filed 2020-07-30
-$582.00K
derived: sum of 3 quarters · filed 2021-03-25
$117.00K
derived: sum of 4 quarters · filed 2021-03-25
2019-03-31$205.00K
10-Q · filed 2020-04-30
-$690.00K
derived: sum of 2 quarters · filed 2021-03-25
$9.00K
derived: sum of 3 quarters · filed 2021-03-25
-$35.00K
derived: sum of 4 quarters · filed 2021-03-25
2018-12-31-$895.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25
-$196.00K
derived: sum of 2 quarters · filed 2021-03-25
-$240.00K
derived: sum of 3 quarters · filed 2021-03-25
-$187.00K
10-K · filed 2021-03-25
2018-09-30$699.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29
$655.00K
derived: sum of 2 quarters · filed 2019-10-29
$708.00K
10-Q · filed 2019-10-29
$747.00K
derived: sum of 4 quarters · filed 2020-03-09
2018-06-30-$44.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01
$9.00K
10-Q · filed 2019-08-01
$48.00K
derived: sum of 3 quarters · filed 2020-03-09
-$131.00K
derived: sum of 4 quarters · filed 2020-03-09
2018-03-31$53.00K
10-Q · filed 2019-05-09
$92.00K
derived: sum of 2 quarters · filed 2020-03-09
-$87.00K
derived: sum of 3 quarters · filed 2020-03-09
$160.00K
derived: sum of 4 quarters · filed 2020-03-09
2017-12-31$39.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09
-$140.00K
derived: sum of 2 quarters · filed 2020-03-09
$107.00K
derived: sum of 3 quarters · filed 2020-03-09
$44.00K
10-K · filed 2020-03-09
2017-09-30-$179.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01
$68.00K
derived: sum of 2 quarters · filed 2018-11-01
$5.00K
10-Q · filed 2018-11-01
$228.00K
derived: sum of 4 quarters · filed 2019-03-07
2017-06-30$247.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
$184.00K
10-Q · filed 2018-08-02
$407.00K
derived: sum of 3 quarters · filed 2019-03-07
-$22.00K
derived: sum of 4 quarters · filed 2019-03-07
2017-03-31-$63.00K
10-Q · filed 2018-05-03
$160.00K
derived: sum of 2 quarters · filed 2019-03-07
-$269.00K
derived: sum of 3 quarters · filed 2019-03-07
-$700.00K
derived: sum of 4 quarters · filed 2019-03-07
2016-12-31$223.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07
-$206.00K
derived: sum of 2 quarters · filed 2019-03-07
-$637.00K
derived: sum of 3 quarters · filed 2019-03-07
-$290.00K
10-K · filed 2019-03-07
2016-09-30-$429.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02
-$860.00K
derived: sum of 2 quarters · filed 2017-11-02
-$513.00K
10-Q · filed 2017-11-02
-$12.00K
derived: sum of 4 quarters · filed 2018-03-01
2016-06-30-$431.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03
-$84.00K
10-Q · filed 2017-08-03
$417.00K
derived: sum of 3 quarters · filed 2018-03-01
$978.00K
derived: sum of 4 quarters · filed 2018-03-01
2016-03-31$347.00K
10-Q · filed 2017-05-04
$848.00K
derived: sum of 2 quarters · filed 2018-03-01
$1.41M
derived: sum of 3 quarters · filed 2018-03-01
$1.41M
derived: sum of 4 quarters · filed 2018-03-01
2015-12-31$501.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01
$1.06M
derived: sum of 2 quarters · filed 2018-03-01
$1.07M
derived: sum of 3 quarters · filed 2018-03-01
$1.26M
10-K · filed 2018-03-01
2015-09-30$561.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
$566.00K
derived: sum of 2 quarters · filed 2016-11-03
$764.00K
10-Q · filed 2016-11-03
2015-06-30$5.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
$203.00K
10-Q · filed 2016-08-04
2015-03-31$198.00K
10-Q · filed 2016-05-05
2014-12-31$12.00K
10-K · filed 2017-03-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Arbutus Biopharma Corp (ABUS)$0.965B6.19
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
Savara Inc (SVRA)United States$1.044B-9.10
Jade Biosciences, Inc. (JBIO)United States$0.936B-9.21
MANNKIND CORP (MNKD)United States$1.058B-30.41
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
Apnimed, Inc. (APMD)United States$0.899B